Myungmoon denies Teva’s takeover

Published: 2012-11-05 07:00:00
Updated: 2012-11-05 07:00:00
Myungmoon Pharm Thursday dismissed the report of M&A (merger and acquisition) with Israel’s generic giant Teva Pharmaceutical Industries.

Ahn Do-gul, a ministry official of Health and Welfare, said Wednesday that Teva is negotiating with Korea’ mid-sized drug firm worth of 100 to 200 billion w...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.